Journal Article

Suppressors of Cytokine Signaling Are Decreased in Major Depressive Disorder Patients

Kobayashi, Nobuyuki, Kondo, Kazuhiro, Shigeta, Masahiro, Nagata, Tomoyuki, Shinagawa, Shunichiro

2022

Overview

There is strong evidence for an association between major depressive disorder (MDD) and inflammation. However, some studies have not observed an increase in inflammatory cytokines in MDD, and the mechanism behind this is unknown. In the present study, we evaluated MDD severity using the Montgomery–Åsberg Depression Rating Scale (MADRS) and quantified mRNA levels of the blood inflammatory cytokines interleukin (IL) 1β, IL-6 and tumor necrosis factor alpha (TNF-α), as well as negative regulators of cytokine signaling—comprising IL-10, IL-1RA, SOCS1, SOCS2 and SOCS3—in MDD patients (n = 36), with a focus on mild MDD, and normal controls (NC, n = 30). We also measured the serum levels of IL-1β and IL-6. Neither the blood mRNA nor the protein levels of inflammatory cytokines were significantly elevated in the MDD group compared with the NC group. However, we observed significant decreases in SOCS1, SOCS2 and SOCS3 mRNA in the MDD group compared to the NC group. A significant finding was a decrease in SOCS3 mRNA after remission from MDD, suggesting that SOCS3 is a trait marker in depressive symptoms. We consider that our findings would be useful in elucidating the pathophysiological mechanism of depression.

• Publisher: MDPI AG,MDPI
• Subject: Autoimmune diseases / Body mass index / Cytokines / Gene expression / IL-1β / Inflammation / Interleukin 1 receptor antagonist / Interleukin 1 receptors / Interleukin 10 / Interleukin 6 / Mental depression / mRNA / Precision medicine / Proteins / Psychiatrists / Remission / Serum levels / Software / Tumor necrosis factor-TNF / Tumor necrosis factor-α